Compositions and methods for the treatment of neuromyelitis optica
摘要
<p>The present invention is directed to antibodies binding to aquaporin 4 (AQP4) and methods of using such antibodies to treat neuromyelitis optica (NMO) either as a monotherapy or in combination with standard NMO therapies such as immunosuppressives or plasmaphersis.</p>
申请公布号
AU2012245205(A1)
申请公布日期
2013.10.31
申请号
AU20120245205
申请日期
2012.04.23
申请人
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, A CALIFORNIA CORPORATION;THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODYCORPORATE
发明人
BENNETT, JEFFREY L.;OWENS, GREGORY P.;VERKMAN, ALAN S.
